Autolus Therapeutics Plc (AUTL)
1.31
+0.03
(+2.34%)
USD |
NASDAQ |
Nov 09, 16:00
1.36
+0.05
(+3.82%)
After-Hours: 19:36
Autolus Therapeutics Total Return Level : 1.28 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 1.28 |
| November 05, 2026 | 1.26 |
| November 04, 2026 | 1.38 |
| November 03, 2026 | 1.415 |
| November 02, 2026 | 1.42 |
| October 30, 2026 | 1.52 |
| October 29, 2026 | 1.58 |
| October 28, 2026 | 1.63 |
| October 27, 2026 | 1.55 |
| October 26, 2026 | 1.53 |
| October 23, 2026 | 1.54 |
| October 22, 2026 | 1.58 |
| October 21, 2026 | 1.62 |
| October 20, 2026 | 1.66 |
| October 19, 2026 | 1.59 |
| October 16, 2026 | 1.60 |
| October 15, 2026 | 1.72 |
| October 14, 2026 | 1.69 |
| October 13, 2026 | 1.62 |
| October 12, 2026 | 1.74 |
| October 09, 2026 | 1.81 |
| October 08, 2026 | 1.77 |
| October 07, 2026 | 1.81 |
| October 06, 2026 | 1.79 |
| October 05, 2026 | 1.83 |
| Date | Value |
|---|---|
| October 02, 2026 | 1.78 |
| October 01, 2026 | 1.85 |
| September 30, 2026 | 1.94 |
| September 29, 2026 | 1.86 |
| September 28, 2026 | 1.86 |
| September 25, 2026 | 1.855 |
| September 24, 2026 | 1.91 |
| September 23, 2026 | 1.95 |
| September 22, 2026 | 2.03 |
| September 21, 2026 | 1.94 |
| September 18, 2026 | 1.94 |
| September 17, 2026 | 1.92 |
| September 16, 2026 | 1.87 |
| September 15, 2026 | 1.89 |
| September 14, 2026 | 1.94 |
| September 11, 2026 | 1.88 |
| September 10, 2026 | 1.96 |
| September 09, 2026 | 2.03 |
| September 08, 2026 | 2.11 |
| September 04, 2026 | 2.24 |
| September 03, 2026 | 2.29 |
| September 02, 2026 | 2.24 |
| September 01, 2026 | 2.31 |
| August 31, 2026 | 2.35 |
| August 28, 2026 | 2.34 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Bicycle Therapeutics Plc | 3.61 |
| Biodexa Pharmaceuticals Plc | 2.480 |
| argenx SE | 927.21 |
| NuCana Plc | 0.9377 |
| Mereo BioPharma Group Plc | 0.283 |